Target intelligence / Profile preview

TonB-dependent iron receptor (TBDR)

Target
TBDR
Molecular classification
Transporter, Receptor, Outer membrane protein
01

Overview

Pseudomonas aeruginosa iron-transport receptors, primarily the TonB-dependent receptors (TBDRs), are essential outer membrane proteins that facilitate the acquisition of iron from the host environment [1, 7]. Iron is a critical nutrient for bacterial growth and virulence, but its availability is limited in the host by sequestering proteins like transferrin and lactoferrin [7, 18]. To overcome this, P. aeruginosa secretes siderophores such as pyoverdine and pyochelin and expresses specific TBDRs like FpvA, FptA, PiuA, and PirA to actively transport iron-siderophore complexes into the cell [8, 17]. Additionally, the bacterium utilizes heme receptors like PhuR and HasR to acquire iron from host hemoproteins [4, 17]. These receptors are exploited by "Trojan horse" antibiotics like cefiderocol, which conjugate a siderophore-like moiety to a beta-lactam core to bypass traditional resistance mechanisms [6, 8]. The active transport of these conjugates through TBDRs allows the drug to reach its periplasmic targets even in the presence of porin loss or efflux pump upregulation [6, 13]. However, mutations in these receptors or their regulatory genes, such as pirR, can lead to reduced drug uptake and the emergence of resistance or heteroresistance [9, 13]. Therapeutic strategies also include the use of iron mimics like gallium, which compete for transport through these systems to disrupt bacterial metabolism [18, 19]. Understanding the diversity and redundancy of these transport systems is crucial for developing effective treatments against multidrug-resistant P. aeruginosa [8, 19].

Other names
Siderophore receptorFerripyoverdine receptorFerripyochelin receptorHeme receptorOuter membrane iron transporterTonB-dependent transporterTBDT
02

Mechanism of action

Siderophore-mediated active transport (Trojan horse strategy)

03

Biological functions

Iron acquisitionSiderophore transportHeme uptakeBacterial growthVirulence regulation
04

Disease associations

InfectionCystic fibrosisPneumoniaBacteremia
05

Safety considerations

Resistance development via receptor mutationHeteroresistanceRedundancy of iron uptake pathwaysPotential for cross-resistance with other beta-lactams
06

Interacting drugs

Cefiderocol

4 more in the full profile.

07

Biomarkers

Siderophore production levelsTonB-dependent receptor mRNA expressionCefiderocol minimum inhibitory concentration (MIC)

Beyond the preview

Go deeper on TonB-dependent iron receptor (TBDR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TonB-dependent iron receptor (TBDR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call